Selected research
Market Analysis & Forecast
Global Lurasidone Market Analysis and Forecast 2026-2032
Market perspective
The global Lurasidone market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Lurasidone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Lurasidone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Lurasidone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Lurasidone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Lurasidone include Zhejiang Hisun Pharmaceutical Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., Square Pharmaceuticals Ltd., RemedyRepack，Inc., Incepta Pharmaceuticals Ltd., Healthcare Pharmaceuticals Limited, Bushu Pharmaceutical, LTD. and Angelini Holding S.p.A., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Lurasidone, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Lurasidone, also provides the sales of main regions and countries. Of the upcoming market potential for Lurasidone, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Lurasidone sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Lurasidone market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Lurasidone sales, projected growth trends, production technology, application and end-user industry.
Lurasidone Segment by Company
Zhejiang Hisun Pharmaceutical Co., Ltd.
Sumitomo Dainippon Pharma Co., Ltd.
Square Pharmaceuticals Ltd.
RemedyRepack，Inc.
Incepta Pharmaceuticals Ltd.
Healthcare Pharmaceuticals Limited
Bushu Pharmaceutical, LTD.
Angelini Holding S.p.A.
Lurasidone Segment by Type
120mg/tablet
20mg/tablet
40mg/tablet
60mg/tablet
80mg/tablet
Lurasidone Segment by Application
Hospital
Psychological Clinic
Others
Lurasidone Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lurasidone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lurasidone and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lurasidone.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Lurasidone in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Lurasidone manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lurasidone sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 120mg/tablet
- 20mg/tablet
- 40mg/tablet
- 60mg/tablet
- 80mg/tablet
Applications
- Hospital
- Psychological Clinic
- Others
Companies covered
- Zhejiang Hisun Pharmaceutical Co., Ltd.
- Sumitomo Dainippon Pharma Co., Ltd.
- Square Pharmaceuticals Ltd.
- RemedyRepack，Inc.
- Incepta Pharmaceuticals Ltd.
- Healthcare Pharmaceuticals Limited
- Bushu Pharmaceutical, LTD.
- Angelini Holding S.p.A.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Lurasidone Market by Type
- 1.2.1 Global Lurasidone Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 120mg/tablet
- 1.2.3 20mg/tablet
- 1.2.4 40mg/tablet
- 1.2.5 60mg/tablet
- 1.2.6 80mg/tablet
- 1.3 Lurasidone Market by Application
- 1.3.1 Global Lurasidone Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Psychological Clinic
- 1.3.4 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Lurasidone Market Dynamics
- 2.1 Lurasidone Industry Trends
- 2.2 Lurasidone Industry Drivers
- 2.3 Lurasidone Industry Opportunities and Challenges
- 2.4 Lurasidone Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Lurasidone Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Lurasidone Revenue by Region
- 3.2.1 Global Lurasidone Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Lurasidone Revenue by Region (2021-2026)
- 3.2.3 Global Lurasidone Revenue by Region (2027-2032)
- 3.2.4 Global Lurasidone Revenue Market Share by Region (2021-2032)
- 3.3 Global Lurasidone Sales Estimates and Forecasts 2021-2032
- 3.4 Global Lurasidone Sales by Region
- 3.4.1 Global Lurasidone Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Lurasidone Sales by Region (2021-2026)
- 3.4.3 Global Lurasidone Sales by Region (2027-2032)
- 3.4.4 Global Lurasidone Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Lurasidone Revenue by Manufacturers
- 4.1.1 Global Lurasidone Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Lurasidone Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Lurasidone Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Lurasidone Sales by Manufacturers
- 4.2.1 Global Lurasidone Sales by Manufacturers (2021-2026)
- 4.2.2 Global Lurasidone Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Lurasidone Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Lurasidone Sales Price by Manufacturers (2021-2026)
- 4.4 Global Lurasidone Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Lurasidone Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Lurasidone Manufacturers, Product Type & Application
- 4.7 Global Lurasidone Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Lurasidone Market CR5 and HHI
- 4.8.2 2025 Lurasidone Tier 1, Tier 2, and Tier 3
5 Lurasidone Market by Type
- 5.1 Global Lurasidone Revenue by Type
- 5.1.1 Global Lurasidone Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Lurasidone Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Lurasidone Revenue Market Share by Type (2021-2032)
- 5.2 Global Lurasidone Sales by Type
- 5.2.1 Global Lurasidone Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Lurasidone Sales by Type (2021-2032) & (K Units)
- 5.2.3 Global Lurasidone Sales Market Share by Type (2021-2032)
- 5.3 Global Lurasidone Price by Type
6 Lurasidone Market by Application
- 6.1 Global Lurasidone Revenue by Application
- 6.1.1 Global Lurasidone Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Lurasidone Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Lurasidone Revenue Market Share by Application (2021-2032)
- 6.2 Global Lurasidone Sales by Application
- 6.2.1 Global Lurasidone Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Lurasidone Sales by Application (2021-2032) & (K Units)
- 6.2.3 Global Lurasidone Sales Market Share by Application (2021-2032)
- 6.3 Global Lurasidone Price by Application
7 Company Profiles
- 7.1 Zhejiang Hisun Pharmaceutical Co., Ltd.
- 7.1.1 Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information
- 7.1.2 Zhejiang Hisun Pharmaceutical Co., Ltd. Business Overview
- 7.1.3 Zhejiang Hisun Pharmaceutical Co., Ltd. Lurasidone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Zhejiang Hisun Pharmaceutical Co., Ltd. Lurasidone Product Portfolio
- 7.1.5 Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Developments
- 7.2 Sumitomo Dainippon Pharma Co., Ltd.
- 7.2.1 Sumitomo Dainippon Pharma Co., Ltd. Company Information
- 7.2.2 Sumitomo Dainippon Pharma Co., Ltd. Business Overview
- 7.2.3 Sumitomo Dainippon Pharma Co., Ltd. Lurasidone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Sumitomo Dainippon Pharma Co., Ltd. Lurasidone Product Portfolio
- 7.2.5 Sumitomo Dainippon Pharma Co., Ltd. Recent Developments
- 7.3 Square Pharmaceuticals Ltd.
- 7.3.1 Square Pharmaceuticals Ltd. Company Information
- 7.3.2 Square Pharmaceuticals Ltd. Business Overview
- 7.3.3 Square Pharmaceuticals Ltd. Lurasidone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Square Pharmaceuticals Ltd. Lurasidone Product Portfolio
- 7.3.5 Square Pharmaceuticals Ltd. Recent Developments
- 7.4 RemedyRepack，Inc.
- 7.4.1 RemedyRepack，Inc. Company Information
- 7.4.2 RemedyRepack，Inc. Business Overview
- 7.4.3 RemedyRepack，Inc. Lurasidone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 RemedyRepack，Inc. Lurasidone Product Portfolio
- 7.4.5 RemedyRepack，Inc. Recent Developments
- 7.5 Incepta Pharmaceuticals Ltd.
- 7.5.1 Incepta Pharmaceuticals Ltd. Company Information
- 7.5.2 Incepta Pharmaceuticals Ltd. Business Overview
- 7.5.3 Incepta Pharmaceuticals Ltd. Lurasidone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Incepta Pharmaceuticals Ltd. Lurasidone Product Portfolio
- 7.5.5 Incepta Pharmaceuticals Ltd. Recent Developments
- 7.6 Healthcare Pharmaceuticals Limited
- 7.6.1 Healthcare Pharmaceuticals Limited Company Information
- 7.6.2 Healthcare Pharmaceuticals Limited Business Overview
- 7.6.3 Healthcare Pharmaceuticals Limited Lurasidone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Healthcare Pharmaceuticals Limited Lurasidone Product Portfolio
- 7.6.5 Healthcare Pharmaceuticals Limited Recent Developments
- 7.7 Bushu Pharmaceutical, LTD.
- 7.7.1 Bushu Pharmaceutical, LTD. Company Information
- 7.7.2 Bushu Pharmaceutical, LTD. Business Overview
- 7.7.3 Bushu Pharmaceutical, LTD. Lurasidone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Bushu Pharmaceutical, LTD. Lurasidone Product Portfolio
- 7.7.5 Bushu Pharmaceutical, LTD. Recent Developments
- 7.8 Angelini Holding S.p.A.
- 7.8.1 Angelini Holding S.p.A. Company Information
- 7.8.2 Angelini Holding S.p.A. Business Overview
- 7.8.3 Angelini Holding S.p.A. Lurasidone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Angelini Holding S.p.A. Lurasidone Product Portfolio
- 7.8.5 Angelini Holding S.p.A. Recent Developments
8 North America
- 8.1 North America Lurasidone Market Size by Type
- 8.1.1 North America Lurasidone Revenue by Type (2021-2032)
- 8.1.2 North America Lurasidone Sales by Type (2021-2032)
- 8.1.3 North America Lurasidone Price by Type (2021-2032)
- 8.2 North America Lurasidone Market Size by Application
- 8.2.1 North America Lurasidone Revenue by Application (2021-2032)
- 8.2.2 North America Lurasidone Sales by Application (2021-2032)
- 8.2.3 North America Lurasidone Price by Application (2021-2032)
- 8.3 North America Lurasidone Market Size by Country
- 8.3.1 North America Lurasidone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Lurasidone Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Lurasidone Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
9 Europe
- 9.1 Europe Lurasidone Market Size by Type
- 9.1.1 Europe Lurasidone Revenue by Type (2021-2032)
- 9.1.2 Europe Lurasidone Sales by Type (2021-2032)
- 9.1.3 Europe Lurasidone Price by Type (2021-2032)
- 9.2 Europe Lurasidone Market Size by Application
- 9.2.1 Europe Lurasidone Revenue by Application (2021-2032)
- 9.2.2 Europe Lurasidone Sales by Application (2021-2032)
- 9.2.3 Europe Lurasidone Price by Application (2021-2032)
- 9.3 Europe Lurasidone Market Size by Country
- 9.3.1 Europe Lurasidone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Lurasidone Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Lurasidone Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Netherlands
- 9.3.9 Nordic Countries
10 China
- 10.1 China Lurasidone Market Size by Type
- 10.1.1 China Lurasidone Revenue by Type (2021-2032)
- 10.1.2 China Lurasidone Sales by Type (2021-2032)
- 10.1.3 China Lurasidone Price by Type (2021-2032)
- 10.2 China Lurasidone Market Size by Application
- 10.2.1 China Lurasidone Revenue by Application (2021-2032)
- 10.2.2 China Lurasidone Sales by Application (2021-2032)
- 10.2.3 China Lurasidone Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Lurasidone Market Size by Type
- 11.1.1 Asia Lurasidone Revenue by Type (2021-2032)
- 11.1.2 Asia Lurasidone Sales by Type (2021-2032)
- 11.1.3 Asia Lurasidone Price by Type (2021-2032)
- 11.2 Asia Lurasidone Market Size by Application
- 11.2.1 Asia Lurasidone Revenue by Application (2021-2032)
- 11.2.2 Asia Lurasidone Sales by Application (2021-2032)
- 11.2.3 Asia Lurasidone Price by Application (2021-2032)
- 11.3 Asia Lurasidone Market Size by Country
- 11.3.1 Asia Lurasidone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Lurasidone Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Lurasidone Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Lurasidone Market Size by Type
- 12.1.1 SAMEA Lurasidone Revenue by Type (2021-2032)
- 12.1.2 SAMEA Lurasidone Sales by Type (2021-2032)
- 12.1.3 SAMEA Lurasidone Price by Type (2021-2032)
- 12.2 SAMEA Lurasidone Market Size by Application
- 12.2.1 SAMEA Lurasidone Revenue by Application (2021-2032)
- 12.2.2 SAMEA Lurasidone Sales by Application (2021-2032)
- 12.2.3 SAMEA Lurasidone Price by Application (2021-2032)
- 12.3 SAMEA Lurasidone Market Size by Country
- 12.3.1 SAMEA Lurasidone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Lurasidone Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Lurasidone Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Lurasidone Value Chain Analysis
- 13.1.1 Lurasidone Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Lurasidone Production Mode & Process
- 13.2 Lurasidone Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Lurasidone Distributors
- 13.2.3 Lurasidone Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst